Supplemental Table 2 from Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A-Mutated Advanced Urothelial Carcinoma

Authors :: Sunil Sharma
Joshua D. Schiffman
Bradley R. Cairns
William T. Lowrance
John M. O’Shea
Brian Dalley
Lisa M. Pappas
Alexis Weston
Andrew Butterfield
Timothy J. Parnell
Daniel J. Albertson
Sumati Gupta
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Individual drug characteristics and doses, maximum plasma levels and protein binding of panobinostat and belinostat in the two phase 1 studies

Tools